The bandage, developed by Dr. Ali Tamayol, associate professor, and researchers from the University of Nebraska-Lincoln and Harvard Medical School, is equipped with miniature needles that can be controlled wirelessly—allowing the drugs to be programmed by care providers without even visiting the patient, according to the article. Tamayol is a BMES member.
“This is an important step in engineering advanced bandages that can facilitate the healing of hard to treat wounds,” Tamayol said in the article. “The bandage does not need to be changed continuously.”
Given the range of processes necessary of wound healing, different medications are needed at different stages of tissue regeneration. The bandage—a wearable device—can deliver medicine with minimal invasiveness.
With the platform, the provider can wirelessly control the release of multiple drugs delivered through the miniature needles. These needles are able to penetrate into deeper layers of the wound bed with minimal pain and inflammation. This method proved to be more effective for wound closure and hair growth as compared to the topical administration of drugs, and is also minimally invasive.
The research, recently published in the Advanced Functional Materials journal, was first conducted on cells and later on diabetic mice with full thickness skin injury.
Read more HERE.

Gordana Vunjak-Novakovic Opens BMES Annual Meeting
This is the fifth in a series of articles highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024 Annual...

NIH Prize Competitions: Crowdsourcing Biomedical Innovation
This is the sixth and final article in a series highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024...

NEW CLASSIFICATION SYSTEM DEVELOPED FOR REGENERATIVE CELL-BASED THERAPIES
Dr. Cato T. Laurencin, CEO of The Connecticut Convergence Institute for Translation in Regenerative Engineering at UConn Health, has created a new...

1 min read
IMPROVED BRAIN CHIP FOR PRECISION MEDICINE DEVELOPED AT U OF HOUSTON
The Akay Lab biomedical research team at the University of Houston has improved on a microfluidic brain cancer chip previously developed in their...

UNIVERSITY OF BUFFALO SPINOFF COMPANY WINS CONTRACT TO DEVELOP HIV VACCINE
A University at Buffalo spinoff company has received a $600,000 contract from the National Institutes of Health to pursue development of a vaccine...